105 related articles for article (PubMed ID: 6687599)
1. Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin.
Roos BA; Huber MB; Birnbaum RS; Aron DC; Lindall AW; Lips K; Baylin SB
J Clin Endocrinol Metab; 1983 Apr; 56(4):802-7. PubMed ID: 6687599
[No Abstract] [Full Text] [Related]
2. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
[TBL] [Abstract][Full Text] [Related]
4. Post-translation processing of neurohormonal peptide precursors in a human medullary thyroid carcinoma.
Conlon JM
Horm Metab Res Suppl; 1989; 21():12-5. PubMed ID: 2572526
[TBL] [Abstract][Full Text] [Related]
5. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
Deftos LJ; Boorman GA; Roos BA
Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795
[No Abstract] [Full Text] [Related]
6. A novel calcitonin carboxyl-terminal peptide produced in medullary thyroid carcinoma by alternative RNA processing of the calcitonin/calcitonin gene-related peptide gene.
Minvielle S; Giscard-Dartevelle S; Cohen R; Taboulet J; Labye F; Jullienne A; Rivaille P; Milhaud G; Moukhtar MS; Lasmoles F
J Biol Chem; 1991 Dec; 266(36):24627-31. PubMed ID: 1761559
[TBL] [Abstract][Full Text] [Related]
7. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
Emmertsen K; Nielsen HE; Mosekilde L; Hansen HH
Acta Med Scand; 1980; 207(5):367-9. PubMed ID: 7386230
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid.
Hennessy JF; Gray TK; Cooper CW; Ontjes DA
J Clin Endocrinol Metab; 1973 Jan; 36(1):200-3. PubMed ID: 4681885
[No Abstract] [Full Text] [Related]
9. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
10. [The diagnosis of medullary carcinoma of the thyroid (author's transl)].
Mulder H; Su CA
Dtsch Med Wochenschr; 1977 Apr; 102(13):479-82. PubMed ID: 844427
[TBL] [Abstract][Full Text] [Related]
11. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
[TBL] [Abstract][Full Text] [Related]
12. Salmon and human calcitonin-like peptides coexist in the human thyroid and brain.
Fischer JA; Tobler PH; Henke H; Tschopp FA
J Clin Endocrinol Metab; 1983 Dec; 57(6):1314-6. PubMed ID: 6630419
[TBL] [Abstract][Full Text] [Related]
13. Purification and amino acid sequence of a noncalcitonin secretory peptide derived from preprocalcitonin.
Birnbaum RS; Mahoney W; Roos BA
J Biol Chem; 1983 May; 258(9):5463-6. PubMed ID: 6853528
[TBL] [Abstract][Full Text] [Related]
14. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
Gordin A; Lamberg BA; Pelkonen R; Almqvist S
Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
[TBL] [Abstract][Full Text] [Related]
16. Medullary carcinoma of the thyroid.
Hollenberg CH
Arch Otolaryngol; 1983 Feb; 109(2):103-5. PubMed ID: 6849663
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.
Conlon JM; Grimelius L; Thim L
Biochem J; 1988 Nov; 256(1):245-50. PubMed ID: 3265620
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
19. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
Lichtenberger LM; Singer FR
Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
[TBL] [Abstract][Full Text] [Related]
20. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
